Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-007019-25Phase 4Terminated
Phase 4, open-label, single-arm trial of risperidone in delusional infestation (DP), sponsored by Barts Health NHS Trust. Primary endpoint: Primary: Reduction in standardized psychiatric assessment scores. Started Apr 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-007019-25.